KIT and ovarian cancer: Indeed, STAT3 and Akt/β-catenin pathways have been shown to play an important role in driving the enrichment of breast CSCs [39, 71], and β-catenin has been demonstrated to mediate the effect of KIT on promoting stemness of ovarian cancer [68].